January 5, 2011
Posted by admin
ACT Receives FDA Clearance For Clinical Trials Using ESCs to Treat AMD, Afflicts 10-15 Million Americans
We re-post here our announcement from January 3, and welcome comments and questions.
Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells to Treat Age-Related Macular Degeneration
Represents A Large Market Opportunity, With No Treatments Currently Available
MARLBOROUGH, MA – January 3, 2011. Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the [...]